In addition, the combination of STAT3 inhibitor (i.e., AZD1480) and VEGF inhibitor (i.e., cediranib) significantly reduced GBM volume and microvessel density in murine xenograft models of GBM (de Groot et al., 2012). Here, STAT3 is linked to glioblastoma.